Skip header and navigation

4 records – page 1 of 1.

Advances in peritoneal surface oncology

https://libcat.nshealth.ca/en/permalink/provcat30092
--Berlin, Heidelberg: Springer-Verlag , c2007.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
González-Moreno, Santiago
Place of Publication
Berlin, Heidelberg
Publisher
Springer-Verlag
Date of Publication
c2007
Series Vol.
169
Series Title
Resent results in cancer research
ISBN
9783540307600
Subjects (MeSH)
Carcinoma - therapy
Mesothelioma - therapy
Peritoneal Neoplasms - drug therapy
Peritoneal Neoplasms - surgery
Subjects (LCSH)
Oncology
Abdomen - Surgery
Format
e-Book
Location
Online
Less detail

Asbestos and Mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat41725
Joseph R. Testa, editor. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included. Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothe…
Available Online
View e-Book
Other Authors
Testa, Joseph R.
Responsibility
Joseph R. Testa, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (viii, 407 pages) : 65 illus., 43 illus. in color
Series Title
Current cancer research
ISBN
9783319535609
9783319535586 (print ed.)
ISSN
2199-2584
Subjects (MeSH)
Asbestos - adverse effects
Mesothelioma - etiology
Mesothelioma - genetics
Mesothelioma - therapy
Abstract
This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included. Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases. Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance. Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.
Contents
1. Malignant Mesothelioma: An Asbestos Legacy -- 2. Asbestos and Fibrous Erionite -- 3. Epidemiology of Mesothelioma -- 4. Malignant Pleural Mesothelioma: History, Controversy and Future of a Man-Made Epidemic -- 5. Communities at High Risk in the Third Wave of Mesothelioma -- 6. Mesothelioma Pathology -- 7. Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases -- 8. Germline and Somatic Mutations in Human Mesothelioma and Lessons from Asbestos-Exposed Genetically Engineered Mouse Models -- 9. Gene Signature of Malignant Pleural Mesothelioma -- 10. Cell Signaling and Epigenetic Mechanisms in Mesothelioma -- 11. 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival -- 12. Biomarkers of Response to Asbestos Exposure -- 13. Surgery Approaches in Mesothelioma -- 14. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma -- 15. Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma -- 16. Immunotherapeutic Approaches to Mesothelioma -- 17. Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections -- 18. The Patient's Experience of Malignant Mesothelioma.
Format
e-Book
Location
Online
Less detail

Caring for Patients with Mesothelioma : Principles and Guidelines

https://libcat.nshealth.ca/en/permalink/provcat44381
Mary Hesdorffer, Gleneara E. Bates-Pappas, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos r…
Available Online
View e-Book
Other Authors
Hesdorffer, Mary
Bates-Pappas, Gleneara E.
Responsibility
Mary Hesdorffer, Gleneara E. Bates-Pappas, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (x, 239 p.) : 54 illus., 46 illus. in color
ISBN
9783319962443
9783319962436 (Print ed.)
9783319962450 (Print ed.)
Subjects (MeSH)
Mesothelioma - therapy
Patient Care Planning
Specialty
Pulmonary Medicine
Abstract
This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.
Contents
Part I: Mesothelioma Treatment -- 1. History of Pleural Surgical Treatment -- 2. History Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis and Evolution and Contemporary Application in Peritoneal Mesothelioma -- 3. Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesothelioma -- 4. Radiation Therapy -- Part II: Therapeutic Treatments: Chemotherapy, Biotherapy, and Immunotherapy -- 5. Chemotherapy and Standard Treatment Options -- 6. Caring for Patients During and After Immunotherapy Treatment -- 7. Biotherapy Treatment: Mesothelin-Targeted Therapies -- 8. Care of the Mesothelioma Patient Undergoing Extended Pleurectomy and Decortication -- Part III: Supportive Health Care for Treatment -- 9. Maintaining a Nutritional Diet During and After Active Treatment -- 10. Mesothelioma and Physical Therapy -- 11. Occupational Therapy and Mesothelioma -- 12. Respiratory Therapy and Pulmonary Rehabilitation for Mesothelioma Patients -- 13. Palliative Care Services for Mesothelioma Patients -- 14. Difficult Conversations and Survivorship -- 15. End-of-Life Care -- Part IV: Public Health Impact of Asbestos Worldwide -- 16. Public Health Impact of Asbestos Worldwide: What Is the Current Public Health Impact? -- Part V: The Future of Mesothelioma Research -- 17. Understanding Clinical Trials in Malignant Mesothelioma -- 18. The Future of Mesothelioma Research: Basic Science Research -- Part VI: Patient’s Perspective -- 19. The Impact of the Internet on Mesothelioma Patients: The Good, the Bad, and the Ugly -- 20. Patient Perspective on Mesothelioma Treatment.
Format
e-Book
Location
Online
Less detail

Malignant Mesothelioma : Advances in Pathogenesis, Diagnosis, and Translational Therapies

https://libcat.nshealth.ca/en/permalink/provcat28173
edited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone. --New York, NY: Springer Science+Business Media , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Pass, Harvey I
Other Authors
Vogelzang, Nicholas J
Carbone, Michele
Responsibility
edited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone
Place of Publication
New York, NY
Publisher
Springer Science+Business Media
Date of Publication
c2005
ISBN
9780387282749
Subjects (MeSH)
Mesothelioma - diagnosis
Mesothelioma - pathology
Mesothelioma - therapy
Subjects (LCSH)
Oncology
Pneumology
Thoracic surgery
Format
e-Book
Location
Online
Less detail